CapCof is a Oral Liquid in the Human Otc Drug category. It is labeled and distributed by Capital Pharmaceutical, Llc. The primary component is Codeine Phosphate; Phenylephrine Hydrochloride; Chlorpheniramine Maleate.
Product ID | 29978-420_61473186-c2f3-780e-e053-2a91aa0a57aa |
NDC | 29978-420 |
Product Type | Human Otc Drug |
Proprietary Name | CapCof |
Generic Name | Codeine Phosphate, Phenylephrine Hydrochloride, Chlorpheniramine Maleate |
Dosage Form | Liquid |
Route of Administration | ORAL |
Marketing Start Date | 2010-10-08 |
Marketing Category | OTC MONOGRAPH FINAL / OTC MONOGRAPH FINAL |
Application Number | part341 |
Labeler Name | Capital Pharmaceutical, LLC |
Substance Name | CODEINE PHOSPHATE; PHENYLEPHRINE HYDROCHLORIDE; CHLORPHENIRAMINE MALEATE |
Active Ingredient Strength | 10 mg/5mL; mg/5mL; mg/5mL |
DEA Schedule | CV |
NDC Exclude Flag | N |
Listing Certified Through | 2019-12-31 |
Marketing Start Date | 2010-10-08 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Marketing Start Date | 2010-10-08 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-12 |
Marketing Category | OTC monograph final |
Application Number | part341 |
Product Type | HUMAN OTC DRUG |
Billing Unit | ML |
Marketing Start Date | 2010-10-08 |
Inactivation Date | 2020-01-31 |
Reactivation Date | 2020-03-12 |
Ingredient | Strength |
---|---|
CODEINE PHOSPHATE | 10 mg/5mL |
SPL SET ID: | 1b281052-55e3-42c0-86ae-585799d97960 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
CAPCOF 90709129 not registered Live/Pending |
Nevett, Michael 2021-05-13 |